Generation of iPSCs as a Pooled Culture Using Magnetic Activated Cell Sorting of Newly Reprogrammed Cells
暂无分享,去创建一个
Ying Liu | Daniel J. Rader | Wenli Yang | Stephen A. Duncan | D. Rader | Y. Liu | E. Morrisey | Joseph C. Wu | Wenli Yang | S. Duncan | Katherine J. Slovik | Edward E. Morrisey
[1] Wolfgang Wagner,et al. To Clone or Not to Clone? Induced Pluripotent Stem Cells Can Be Generated in Bulk Culture , 2013, PloS one.
[2] S. Duncan,et al. Differentiation of hepatocytes from pluripotent stem cells. , 2013, Current protocols in stem cell biology.
[3] Yi Zhang,et al. Genetic and epigenetic variations in iPSCs: potential causes and implications for application. , 2013, Cell stem cell.
[4] P. Burridge,et al. Pravastatin reverses obesity-induced dysfunction of induced pluripotent stem cell-derived endothelial cells via a nitric oxide-dependent mechanism. , 2015, European heart journal.
[5] P. Gadue,et al. Generation of human induced pluripotent stem cells from peripheral blood using the STEMCCA lentiviral vector. , 2012, Journal of visualized experiments : JoVE.
[6] Brian S. Clark,et al. JD induced pluripotent stem cell–derived hepatocytes faithfully recapitulate the pathophysiology of familial hypercholesterolemia , 2012, Hepatology.
[7] S. Duncan,et al. Aneuploidy is permissive for hepatocyte-like cell differentiation from human induced pluripotent stem cells , 2014, BMC Research Notes.
[8] Shinya Yamanaka,et al. iPS cells: a game changer for future medicine , 2014, The EMBO journal.
[9] J. Thomson,et al. Embryonic stem cell lines derived from human blastocysts. , 1998, Science.
[10] E. Snyder,et al. Current Protocols in Stem Cell Biology , 2007 .
[11] Stephen Dalton,et al. Highly efficient generation of human hepatocyte–like cells from induced pluripotent stem cells , 2010, Hepatology.
[12] L. Sullivan,et al. Clonal genetic and hematopoietic heterogeneity among human-induced pluripotent stem cell lines. , 2013, Blood.
[13] Y. Liu,et al. iPSC Reprogramming from Human Peripheral Blood Using Sendai Virus Mediated Gene Transfer , 2014 .
[14] G. Daley,et al. Live cell imaging distinguishes bona fide human iPS cells from partially reprogrammed cells , 2009, Nature Biotechnology.
[15] Daniel Paull,et al. Improved Methods for Reprogramming Human Dermal Fibroblasts Using Fluorescence Activated Cell Sorting , 2013, PloS one.
[16] N. Katsanis,et al. Rapid and Efficient Generation of Transgene-Free iPSC from a Small Volume of Cryopreserved Blood , 2015, Stem Cell Reviews and Reports.
[17] T. Cheng,et al. A Facile Method to Establish Human Induced Pluripotent Stem Cells From Adult Blood Cells Under Feeder‐Free and Xeno‐Free Culture Conditions: A Clinically Compliant Approach , 2015, Stem cells translational medicine.
[18] Michael J. Ziller,et al. Reference Maps of Human ES and iPS Cell Variation Enable High-Throughput Characterization of Pluripotent Cell Lines , 2011, Cell.
[19] Bahram Valamehr,et al. A novel platform to enable the high-throughput derivation and characterization of feeder-free human iPSCs , 2012, Scientific Reports.
[20] R. Lafyatis,et al. Generation of Transgene‐Free Lung Disease‐Specific Human Induced Pluripotent Stem Cells Using a Single Excisable Lentiviral Stem Cell Cassette , 2010, Stem cells.
[21] Y. Matsumoto,et al. Genetically Matched Human iPS Cells Reveal that Propensity for Cartilage and Bone Differentiation Differs with Clones, not Cell Type of Origin , 2013, PloS one.
[22] Jarrett Rosenberg,et al. Single cell transcriptional profiling reveals heterogeneity of human induced pluripotent stem cells. , 2011, The Journal of clinical investigation.
[23] Vicky Heath. Differentiation: from α to β , 2010, Nature Reviews Endocrinology.
[24] Ramesh Chandra,et al. Induced pluripotent stem cells: applications in regenerative medicine, disease modeling, and drug discovery , 2015, Front. Cell Dev. Biol..
[25] T. Cantz,et al. Small but significant: inter- and intrapatient variations in iPS cell-based disease modeling. , 2013, Molecular therapy : the journal of the American Society of Gene Therapy.
[26] Xin Ren,et al. COMPARISON OF THE SORTING EFFICIENCY AND INFLUENCE ON CELL FUNCTION BETWEEN THE STERILE FLOW CYTOMETRY AND IMMUNOMAGNETIC BEAD PURIFICATION METHODS , 2013, Preparative biochemistry & biotechnology.
[27] M. Hasegawa,et al. Efficient induction of transgene-free human pluripotent stem cells using a vector based on Sendai virus, an RNA virus that does not integrate into the host genome , 2009, Proceedings of the Japan Academy. Series B, Physical and biological sciences.
[28] P. Cahan,et al. Origins and implications of pluripotent stem cell variability and heterogeneity , 2013, Nature Reviews Molecular Cell Biology.
[29] A. Terzic,et al. Intrapatient variations in type 1 diabetes-specific iPS cell differentiation into insulin-producing cells. , 2013, Molecular therapy : the journal of the American Society of Gene Therapy.
[30] S. Yamanaka,et al. Induction of Pluripotent Stem Cells from Mouse Embryonic and Adult Fibroblast Cultures by Defined Factors , 2006, Cell.